InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: vator post# 1967

Friday, 08/17/2012 4:35:10 PM

Friday, August 17, 2012 4:35:10 PM

Post# of 3720
Again..you are making assumptions without knowing the facts. The protocol for which they received FDA approval for test required 55 and under...dialysis and other requirements for "controlled test". U of Miami never completed enrollment due to "budgetary" concerns and announced severe cut-back in research and layoffs.

Had nothing to do with efficacy of test. So yes, the person he asked would know nothing because the test did not commenced.

U of Miami was paying $3m and Prot $110k (that is thousands, a great deal) for the test costs. Prot paid the U of M the money. U of Miami had an escape clause which they exercised having nothing to do with efficacy. U of Miami was getting a very small %, believe 2% of gross sales. Rumor has it they would have considered commencing if they got a larger %. Company is said to have not wanted to give more. (if true dumb, depending on what they were asking for).

Cream launch was announced for September. They had pre-orders before and were not ready...now set for September. Marketing directly to Dr.s No reason to believe will not be on time. Would have announced by now if not in September or delay IMHO.